Moving up to 10mg Mounjaro: the process, the evidence, the practicalities

10mg is the fourth of six licensed strengths (2.5, 5, 7.5, 10, 12.5, 15 mg) and typically reached after around 12 weeks on treatment, assuming four-week steps at each dose.
In SURMOUNT-1, average weight reduction at 10mg tirzepatide over 72 weeks was around 19.5% — meaningfully greater than lower doses in the same trial.
Side effects at dose increases are usually GI in nature (nausea, loose stools, reduced appetite) and tend to settle within the first week or two at the new level.
A prescriber must confirm suitability before the dose changes — your response, tolerability and overall health picture all factor in.

Moving up to 10mg Mounjaro is the fourth step on the licensed titration schedule, and for many people it marks the point where weight loss begins to accelerate meaningfully. Tirzepatide's dose escalation is gradual by design: each four-week step gives your body time to adjust before the next increase. The 10mg dose sits two steps above the 5mg starting maintenance level, and the clinical evidence shows the stronger doses produce greater average weight reduction. These are prescription-only medicines, so a prescriber assesses whether moving up is right for you before any change is made.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the step to 10mg actually unfolds, and what the evidence says about it

Step 1: confirming you're ready to move up

Before a prescriber approves 10mg, they'll want to know how 7.5mg has been tolerated. The guiding question is straightforward: has the current dose settled? If nausea, vomiting or other GI symptoms are still significant, staying at 7.5mg for another four weeks is often the sensible call. Rushing the schedule tends to compound side effects rather than accelerate results.

You'll also find it worth thinking about the practicalities before requesting the increase. Orders placed before midday Monday to Friday are dispatched the same day if the prescription is approved, arriving with DPD the next working day. If you're approaching a bank holiday or planning a holiday yourself, a quick check of the calendar saves the hassle of a gap in your supply. The consultation is free, and a real clinician reviews your case the same day, your answers go to a GPhC-registered prescriber, not an automated screening tool.

Evidence from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that higher doses consistently produced greater weight reduction. The 10mg arm achieved roughly 19.5% average body-weight loss over 72 weeks in participants without type 2 diabetes, which is why many people and their prescribers choose to keep titrating rather than staying at a lower maintenance level.

If you're still in the earlier stages and want to revisit what the journey to this point looks like, our guide on moving from 2.5mg to 5mg covers that initial step, and the step from 5mg to 7.5mg covers the logic of that transition in full.

Step 2: what 10mg actually does differently

Tirzepatide works by activating both GIP and GLP-1 receptors, the two gut hormones most closely involved in appetite regulation and blood-sugar control. At 10mg the receptor engagement is stronger than at lower doses, which typically translates to a more pronounced reduction in hunger and, for most people, a noticeable shift in how much they want to eat at meals.

Gastric emptying slows further, which can intensify the fullness signal but may also mean that food-related nausea is more noticeable in the first one to two weeks at the new dose. This is the same pattern seen at earlier transitions, it's the body recalibrating, not a sign that the treatment isn't working. The NHS medicines page for tirzepatide lists the common GI effects in plain language and is worth bookmarking for reference during any dose change.

The injection technique itself doesn't change. You're still using the same KwikPen format, rotating between the abdomen, thigh and upper arm, with a clean technique at each site. If you have questions about any aspect of how the pen works at this strength, the 10mg pen guide covers the format in detail, and the Patient Information Leaflet included with your pen remains the definitive reference for storage and administration specifics.

People often ask whether the jump from 7.5mg to 10mg feels bigger than earlier steps. The honest answer is that individual responses vary, some find it the smoothest transition yet, others notice a brief return of nausea they thought they'd left behind. Both are normal.

Step 3: managing the transition period

The four weeks after moving to 10mg are when most people experience any adjustment effects. Staying well hydrated is the single most consistently useful practical step: slower gastric emptying combined with reduced appetite means it's easy to let fluid intake slip without noticing. Small, lower-fat meals more frequently tend to be easier to tolerate than larger ones, particularly in the first two weeks.

Protein deserves particular attention at this stage. As overall calorie intake falls, preserving lean mass requires conscious effort, NHS guidance on healthy eating alongside weight-management treatment makes this point clearly. If you find your appetite suppression is very strong, working through what to eat (rather than just how much) with a dietitian or your prescribing team makes a real difference.

Cost is occasionally something patients raise at this point in treatment. The Mounjaro pricing page gives honest context on what private treatment costs at different doses and what a legitimate price includes. One transparent figure covers consultation, prescription, the medicine itself and free next-working-day delivery, there are no separate add-on charges at any dose. NICE's appraisal of tirzepatide, TA1026, sets out the evidence base the clinical community uses to guide decisions about this medicine, and the eligibility criteria it describes help explain why prescribers assess each step carefully.

If side effects at 10mg feel unmanageable rather than just uncomfortable, contact your prescribing team. Staying at the current dose longer is always an option; so is a structured conversation about whether 12.5mg is likely to follow. The Mounjaro overview explains the full six-step schedule for anyone who wants to see the whole picture before committing to the next stage.

When the dose increase requires a pause or a prescriber conversation

Not every move to 10mg is straightforward, and that's not unusual. If you experienced significant side effects at 7.5mg that haven't settled, your prescriber may recommend staying put rather than escalating. The licensed schedule is a framework, not a fixed timetable.

There are also specific situations where a prescriber will want to review the full picture before agreeing to an increase: persistent nausea or vomiting that's affecting your ability to eat or drink normally, any new symptoms that have appeared since the last dose step, or a change in your health circumstances. Severe abdominal pain that radiates to the back should prompt you to seek urgent medical help, not wait for your next scheduled consultation.

Transfer patients arriving at 10mg from another provider will be asked to provide evidence of their current treatment and dose history. This isn't bureaucracy for its own sake, it's the clinical safety standard that protects you. Our clinical team, which you can read about here, applies this to every dose increase rather than treating any step as automatic. If you are newer to treatment and want to understand what moving up to 5mg involves before considering higher doses, that guidance is also available. For a broader look at how treatment eligibility and the consultation process work, the weight-loss treatment overview is a useful starting point before you take things further.

When you're ready to check whether 10mg is the right next step for you, our prescribers are available seven days a week for aftercare queries and every weekday for new consultations.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions